# Nobelpharma clinical trials: 34 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 34 trials with Nobelpharma as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Nobelpharma: 34 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/nobelpharma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 34
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 34, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 10, 2022 | NCT05495425 | Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC | Nobelpharma | Phase 3 | Completed | Tuberous Sclerosis Complex | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05495425) |
| July 29, 2022 | NCT05480553 | NPC-06 to Pain Associated With Acute Herpes Zoster | Nobelpharma | Phase 3 | Completed | Acute Pain in Herpes Zoster | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05480553) |
| December 17, 2020 | NCT04671472 | Efficacy Confirmation Study of NPC-09 | Nobelpharma | Phase 3 | Completed | GNE Myopathy, Distal Myopathy With Rimmed Vacuoles (DMRV), Hereditary Inclusion Body Myopathy (hIBM), Nonaka Disease | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04671472) |
| November 24, 2020 | NCT04642950 | A Phase II/III Study of Sargramostim | Nobelpharma | Phase 2/3 | Completed | COVID-19 | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04642950) |
| August 7, 2020 | NCT04503863 | An Additional Study of NPC-22 in Healthy Adult Males | Nobelpharma | Phase 1 | Completed | Safety and Pharmacokinetics | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04503863) |
| July 8, 2020 | NCT04461886 | A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I | Nobelpharma | Phase 3 | Terminated | Neurofibromatosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04461886) |
| January 13, 2020 | NCT04225923 | A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection | Nobelpharma | Phase 2 | Completed | Cytomegalovirus Disease | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04225923) |
| December 18, 2019 | NCT04203862 | A Study of NPC-22 in Healthy Adult Males | Nobelpharma | Phase 1 | Completed | Healthy Adult Subjects | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04203862) |
| October 25, 2019 | NCT04139330 | NPC-06 to Acute Pain in Herpes Zoster | Nobelpharma | Phase 2 | Terminated | Acute Pain in Herpes Zoster | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04139330) |
| June 3, 2019 | NCT03972462 | NPC-12G Gel 0.2% Sirolimus PK Bridging Study | Nobelpharma | Phase 1 | Completed | Bioavailability Study | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03972462) |
| December 12, 2018 | NCT03773055 | Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer | Nobelpharma | Phase 2 | Terminated | Neuropathic Pain in Cancer | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03773055) |
| December 5, 2018 | NCT03765944 | Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets | Nobelpharma | Phase 1 | Completed | Bioequivalence Study | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03765944) |
| March 23, 2018 | NCT03475459 | Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7) | Nobelpharma | Phase 1 | Completed | Qt Interval, Variation in | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03475459) |
| April 29, 2016 | NCT02757079 | Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders | Nobelpharma | Phase 3 | Completed | Sleep Disorders, Neurodevelopmental Disorder | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02757079) |
| April 29, 2016 | NCT02757066 | Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders | Nobelpharma | Phase 2/3 | Completed | Sleep Disorders, Autism Spectrum Disorder | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02757066) |
| December 21, 2015 | NCT02635789 | Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | Nobelpharma | Phase 3 | Completed | Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule, Plaque | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02635789) |
| December 18, 2015 | NCT02634931 | Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex | Nobelpharma | Phase 3 | Completed | Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule, Plaque | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02634931) |
| February 13, 2015 | NCT02362711 | Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea | Nobelpharma | Phase 3 | Completed | Dysmenorrhea | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02362711) |
| January 13, 2015 | NCT02337569 | A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency | Nobelpharma | Phase 3 | Completed | Zinc Deficiency | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02337569) |
| December 22, 2014 | NCT02321865 | Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency | Nobelpharma | Phase 3 | Completed | Zinc Deficiency | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02321865) |
| August 3, 2011 | NCT01408173 | Clinical Study of Caffeine for Apnea of Prematurity | Nobelpharma | Phase 3 | Completed | Apnea of Prematurity | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01408173) |
| December 3, 2010 | NCT01253824 | Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers | Nobelpharma | Phase 3 | Completed | Healthy | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01253824) |
| November 23, 2010 | NCT01246791 | Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers | Nobelpharma | Phase 3 | Completed | Healthy | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01246791) |
| July 22, 2010 | NCT01167322 | Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas | Nobelpharma | Phase 3 | Completed | Malignant Glioma | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01167322) |
| May 24, 2010 | NCT01129102 | Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea | Nobelpharma | Phase 3 | Completed | Dysmenorrhea | 215 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01129102) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Phase 2/3 | 3 |
| Phase 3 | 22 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 31 |
| Terminated | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Dysmenorrhea | 6 |
| Tuberous Sclerosis | 3 |
| Angiofibroma | 2 |
| Plaque, Amyloid | 2 |
| Sleep Wake Disorders | 2 |
| Glioma | 2 |
| Neurofibromatoses | 1 |
| Neurodevelopmental Disorders | 1 |
| Seizures | 1 |
| COVID-19 | 1 |
| Apnea | 1 |
| Premature Birth | 1 |
| Hepatolenticular Degeneration | 1 |
| Autism Spectrum Disorder | 1 |
| Epilepsy | 1 |
| Distal myopathy, Nonaka type | 1 |
| Herpes Zoster | 1 |
| Acute Pain | 1 |
| Cytomegalovirus Infections | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Demolition contractors in the United States](https://specstream.ai/data/businesses/demolition-contractors/united-states)
- [Italian restaurants in the United States](https://specstream.ai/data/businesses/italian-restaurants/united-states)
- [Restaurant equipment suppliers in the United States](https://specstream.ai/data/businesses/restaurant-equipment-suppliers/united-states)
- [Assisted living facilities in the United States](https://specstream.ai/data/businesses/assisted-living-facilities/united-states)
- [Educational research institutes in the United States](https://specstream.ai/data/businesses/educational-research-institutes/united-states)
- [Logging companies in the United States](https://specstream.ai/data/businesses/logging-companies/united-states)
